New Drugs & OTCs

03/26/2014 - 1:58pm

Actavis and Valeant Pharmaceuticals International announced that the Food and Drug Administration approved the new drug application for Metronidazole 1.3% vaginal gel. The antibiotic is used for the treatment of bacterial vaginosis, an infection caused by an imbalance in the normal bacteria of vagina.

03/26/2014 - 9:50am

Perrigo announced that its Nutritionals segment is partnering with KanPak to manufacture store brand adult nutritional drinks comparable to Ensure products.

03/26/2014 - 9:08am

Zarbee's Naturals launched Seasonal Relief with Ze339, an extract from Butterbur that helps relieve congestion, the company reported.

03/26/2014 - 8:56am

Drive Medical on Tuesday introduced the Bariatric Rollator walker.

03/24/2014 - 12:40pm

Genentech announced that the Food and Drug Administration approved Xolair (omalizumab) for the treatment of chronic idiopathic urticaria, or CIU, which is a form of chronic hives.

03/24/2014 - 8:24am

Celgene on Friday announced that the Food and Drug Administration has approved Otezla (apremilast), the company's oral, selective inhibitor of phosphodiesterase 4 (PDE4), for the treatment of adult patients with active psoriatic arthritis.

03/21/2014 - 12:23pm

Pharma Major Lupin announced that Lupin Pharmaceuticals, its U.S. subsidiary, has launched niacin extended-release tablets USP in 500-mg, 750-mg and 1,000-mg strengths.

03/21/2014 - 12:10pm

Skinnygirl brand has already made its foray into several categories, including a recent line of water flavor enhancers and a partnership with SodaStream to create new flavors. Now the brand will step into the supplement category with its new Skinnygirl Supplements.

03/21/2014 - 8:48am

Danish pharmaceutical group Alk Abello, in association with Merck, expects to start selling its new dust mite allergy tablet in the United States in 2017, according to a Reuters report published Thursday.

© 2014 Drug Store News. All Rights Reserved.